FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention refers to pharmaceutics and medicine, namely to an antimicrobial pharmaceutical composition in the form of effervescent tablets containing nitrofural. Composition contains as an active substance nitrofural, as auxiliary substances sodium chloride, gas-forming mixture, acidity regulator and binder, in quantities specified in the patent claim. Effervescent tablets of nitrofural are prepared by wet granulation. Antimicrobial composition may optionally contain a lubricant and sodium lauryl sulphate.
EFFECT: invention provides wider range of antimicrobial medicinal agents, high granulation effluent for tableting and high strength of tablets for crushing.
14 cl, 4 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING NITROFURAL, IN THE FORM OF EFFERVESCENT TABLETS (VERSIONS) | 2019 |
|
RU2696568C1 |
ANTIMICROBIAL THERAPEUTIC PREPARATION IN FORM OF FAST-DISSOLVING EFFERVESCENT TABLET | 2013 |
|
RU2533261C1 |
ANTIMICROBIAL MEDICINAL PREPARATION IN THE FORM OF TABLETS OF FURACILIN WITH ACCELERATED RELEASE | 2019 |
|
RU2696573C1 |
MEANS FOR PREPARING AN ANTIBACTERIAL TREATMENT SOLUTION, METHOD OF PROVIDING MEANS FOR PREPARING AN ANTIBACTERIAL TREATMENT SOLUTION | 2022 |
|
RU2789736C1 |
COMPOSITION AND METHOD FOR PREPARING RAPIDLY SOLUBLE ANTIFUNGAL DRUG BASED ON NITROFURAL | 2017 |
|
RU2692772C2 |
COMPOSITION AND METHOD FOR PREPARING A RAPIDLY SOLUBLE ANTIMICROBIAL DRUG BASED ON NITROFURAL (VERSIONS) | 2018 |
|
RU2712123C1 |
RAPIDLY DISSOLVING DOSAGE FORM OF FURAZOLIDONE AND METHOD FOR PRODUCTION THEREOF | 2021 |
|
RU2772430C1 |
INSTANTLY SOLUBLE DOSAGE FORM OF METRONIDAZOLE AND METHOD OF ITS OBTAINING (VERSIONS) | 2021 |
|
RU2797947C2 |
MEANS FOR PREPARATION OF ANTIMICROBIAL THERAPEUTIC SOLUTION (OPTIONS), METHOD FOR ORGANIZATION OF MEANS FOR PREPARATION OF ANTIMICROBIAL THERAPEUTIC SOLUTION (OPTIONS) | 2020 |
|
RU2779613C2 |
SOLUBLE SPARKLING THERAPEUTIC COMPOSITION | 1999 |
|
RU2155033C1 |
Authors
Dates
2019-08-21—Published
2017-11-01—Filed